Mineralocorticoid receptor in cardiovascular diseases—Clinical trials and mechanistic insights-Reference-Cited by-同舟云学术

Mineralocorticoid receptor in cardiovascular diseases—Clinical trials and mechanistic insights

Published:2021-11-17 Issue: Volume: Page:
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:British J Pharmacology

Author:

Bauersachs Johann¹^ORCID,López‐Andrés Natalia²^ORCID

Affiliation:

1. Department of Cardiology and Angiology Hannover Medical School Hannover Germany

2. Cardiovascular Translational Research. Navarrabiomed (Miguel Servet Foundation), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Complejo Hospitalario de Navarra (CHN) Universidad Pública de Navarra (UPNA) Pamplona Spain

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bph.15708

Reference137 articles.

1. Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine

2. THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors

3. THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Nuclear hormone receptors

4. Spironolactone Decreases DOCA–Salt–Induced Organ Damage by Blocking the Activation of T Helper 17 and the Downregulation of Regulatory T Lymphocytes

5. Efficacy and Safety of Early Initiation of Eplerenone Treatment in Patients with Acute Heart Failure (EARLIER trial): a multicentre, randomized, double-blind, placebo-controlled trial

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mineralocorticoid Receptor Antagonism Prevents Aortic Plaque Progression and Reduces Left Ventricular Mass and Fibrosis in Patients With Type 2 Diabetes and Chronic Kidney Disease: The MAGMA Trial;Circulation;2024-08-27

2. Roles of distinct nuclear receptors in diabetic cardiomyopathy;Frontiers in Pharmacology;2024-07-24

3. Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment;Clinical Research in Cardiology;2024-04-11

4. Lessons learned from early-stage clinical trials for diabetic nephropathy;Expert Opinion on Investigational Drugs;2024-03-15

5. Evidence for the druggability of aldosterone targets in heart failure: A bioinformatics and data science-driven decision-making approach;Computers in Biology and Medicine;2024-03